Triton Therapeutics, Inc.

CIK 2088152 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Triton Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 23, 2025D0002088152-25-000001